Cargando…

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?

Detalles Bibliográficos
Autores principales: Chhatwal, Jagpreet, Basu, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933136/
https://www.ncbi.nlm.nih.gov/pubmed/35315330
http://dx.doi.org/10.1016/j.jval.2022.02.002
_version_ 1784671579156774912
author Chhatwal, Jagpreet
Basu, Anirban
author_facet Chhatwal, Jagpreet
Basu, Anirban
author_sort Chhatwal, Jagpreet
collection PubMed
description
format Online
Article
Text
id pubmed-8933136
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89331362022-03-21 Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing? Chhatwal, Jagpreet Basu, Anirban Value Health Themed Section: COVID-19 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. 2022-05 2022-03-19 /pmc/articles/PMC8933136/ /pubmed/35315330 http://dx.doi.org/10.1016/j.jval.2022.02.002 Text en © 2022 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Themed Section: COVID-19
Chhatwal, Jagpreet
Basu, Anirban
Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
title Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
title_full Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
title_fullStr Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
title_full_unstemmed Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
title_short Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
title_sort cost-effectiveness of remdesivir for covid-19 treatment: what are we missing?
topic Themed Section: COVID-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933136/
https://www.ncbi.nlm.nih.gov/pubmed/35315330
http://dx.doi.org/10.1016/j.jval.2022.02.002
work_keys_str_mv AT chhatwaljagpreet costeffectivenessofremdesivirforcovid19treatmentwhatarewemissing
AT basuanirban costeffectivenessofremdesivirforcovid19treatmentwhatarewemissing